Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Lucca – page 3

39 clinical trials in Lucca, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Lucca at a glance
39
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

39 trials in Lucca

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Universita Degli Studi Di Padova
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Bergenbio ASA
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:Fondazione GONO G.I.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Inupadenant Hydrochloride
  • Sponsor:iTeos Belgium
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Gilead Sciences Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Gilead Sciences Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Daiichi Sankyo Inc.
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Lucca

What the registry says about research in the country

01 Lung Cancer Research

Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including novel combination therapies and targeted approaches for various disease stages.

  • Advanced and metastatic NSCLC treatments
  • Immunotherapy combinations
  • Targeted therapies for specific mutations

Studies evaluating innovative drug sequences and therapeutic combinations to improve patient outcomes.

02 Breast Cancer Studies

Comprehensive research on triple-negative breast cancer and hormone receptor-related conditions, investigating new treatment approaches.

  • Neoadjuvant therapy evaluation
  • Immunotherapy combinations
  • Targeted therapeutic approaches

Focus on improving treatment efficacy through novel drug combinations and sequencing strategies.

03 Gynecologic Oncology

Trials examining treatments for ovarian cancer and endometrial cancer, with emphasis on maintenance therapies and novel drug combinations.

  • Platinum-sensitive disease management
  • Maintenance therapy strategies
  • Advanced stage treatments

Investigation of targeted therapies and immunotherapy approaches for gynecologic cancers.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.